Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

NCT00463086 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1368

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Latent Tuberculosis Infection
HIV Infections

Interventions

DRUG: isoniazid
DRUG: Placebo

Sponsor

University of Cape Town

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]